SCHEMBL18976462

SCHEMBL18976462

Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)Nc1ccc2oc(C(=O)N3CCCCC3)cc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HRAS P01112 4/20 0.43
▸ ESR1 P03372 4/20 0.43
▸ ESR2 Q92731 4/20 0.43
▸ HPGD P15428 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HRH4 Q9H3N8 2/20 0.42
▸ POLB P06746 1/20 0.41
▸ ACHE P22303 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ SYK P43405 1/20 0.39
▸ TPSAB1 Q15661 1/20 0.38
▸ TPSD1 Q9BZJ3 1/20 0.38
▸ TPSG1 Q9NRR2 1/20 0.38
▸ PRKDC P78527 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18976206 0.92 RAB9A (0.46) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL18976466 0.92 HRAS (0.41) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL20580855 0.87 RAB9A (0.50) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL18954276 0.87 HRAS (0.40) ALDH1A1MAPTLMNASMN1; SMN2HRAS
SCHEMBL18976174 0.87 HRAS (0.39) ALDH1A1MAPTLMNASMN1; SMN2HRAS
SCHEMBL18976175 0.86 HRAS (0.45) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL18976463 0.84 HRAS (0.45) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL18976141 0.83 AR (0.51) LMNAPOLBACHEBACE1NR1I3
SCHEMBL18976322 0.82 HRAS (0.46) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL18975731 0.82 AR (0.52) LMNAPOLBACHEBACE1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
WO-2017098257-A1 PBD ANTIBACTERIAL AGENTS KING'S COLLEGE LONDON (GB) 2017-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS NPC1 2404/4885RAB9A 3045/4885ALDH1A1 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback